Brown Advisory’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,423,862
Closed -$27.8M 1246
2022
Q4
$27.8M Sell
1,423,862
-79,884
-5% -$1.56M 0.05% 271
2022
Q3
$36.2M Sell
1,503,746
-16,590
-1% -$511K 0.07% 221
2022
Q2
$47.8M Sell
1,520,336
-36,899
-2% -$1.34M 0.09% 179
2022
Q1
$68.5M Buy
1,557,235
+126,356
+9% +$5.43M 0.1% 158
2021
Q4
$62.2M Buy
1,430,879
+286,341
+25% +$11.2M 0.08% 189
2021
Q3
$35.8M Buy
1,144,538
+253,688
+28% +$9.98M 0.05% 233
2021
Q2
$37.7M Buy
890,850
+884,225
+13,347% +$34.4M 0.06% 232
2021
Q1
$249K Buy
+6,625
New +$207K ﹤0.01% 989

Other funds holding ACH

Brown Advisory's ACH Position: Q1 2023 in Review

Brown Advisory sold out of Accendra Health (ACH) in Q1 2023, closing a stake of 1,423,862 shares — an estimated $27.8M sold.

Brown Advisory first reported a position in ACH in Q1 2021 and held it in 8 quarters. The position peaked at $68.5M in Q1 2022. 217 funds tracked by Wall St. Rank hold ACH as of Q1 2023.

  • Brown Advisory reported no remaining Accendra Health position as of Q1 2023 after selling out during the quarter.
  • Brown Advisory sold 1,423,862 Accendra Health shares in Q1 2023, an estimated $27.8M.
  • Brown Advisory first reported a position in Accendra Health in Q1 2021 and held it in 8 quarters.
  • Brown Advisory's Accendra Health position peaked at $68.5M in Q1 2022.
  • 217 funds tracked by Wall St. Rank held Accendra Health as of Q1 2023.

Based on Brown Advisory's 13F filing for Q1 2023, filed 8 May 2023.